Table 1. Baseline characteristics (380 patients).

Variables	Number (%)/mean ± SD
Age, years	54.3±12.3
Sex, male/female	311 (81.8)/69 (18.2)
Aetiology, HBV/non-HBV	320 (84.2)/60 (15.8)
BCLC stage, A/B/C	57 (15.0)/207 (54.5)/116 (30.5)
Child-Pugh class, A/B	351 (93.1)/26 (6.9)
Tumour size (cm)	7.9±3.8
Tumour number, single/multiple	239 (62.9)/141 (37.1)
AFP, ≤400/>400 ng/mL/NA	218 (57.4)/160 (42.1)/2 (0.5)
Baseline laboratory assessments
Alanine aminotransferase (U/L)	45.2±30.2
Aspartate aminotransferase (U/L)	56.1±46.2
Albumin, g/L	38.8±5.2
Total bilirubin, μmol/L	16.9±7.6
Serum creatinine, mg/d	0.85±0.8

AFP, alpha-fetoprotein; BCLC, Barcelona clinic liver cancer.